ODYSSEY THERAPEUTICS
Odyssey Therapeutics is a biotechnology company pioneering the efficient development of next-generation immunomodulators and oncology medicines. Odyssey is making a transformational impact on the field of drug discovery and is accelerating the path to clinical development to drive the creation of more effective precision medicines.
ODYSSEY THERAPEUTICS
Industry:
Biotechnology Health Care
Founded:
2021-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.odysseytx.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
218 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome Domain Not Resolving Global Site Tag
Similar Organizations
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Cadent Therapeutics
Cadent Therapeutics develops novel medicines that tune and modulate brain rhythms for patients with serious neurological disease.
Clade Therapeutics
Clade Therapeutics discovers and delivers next-generation cell medicines to improve the lives of patients.
Modis Therapeutics
Modis Therapeutics is bringing disease-modifying therapies to patients with rare genetic diseases.
PijnZorg
PijnZorg provides its clients with treatment for inflammatory pain.
Resilience
Resilience provides treatment for cancer.
Bloomwell Group
Bloomwell Group provides easy access to natural based medicine.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
ValenzaBio
ValenzaBio is developing safe and effective treatment options for patients with autoimmune and inflammatory diseases.
Current Advisors List
Current Employees Featured
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-12-13 | Rahko | Rahko acquired by Odyssey Therapeutics | N/A |
Investors List
HBM Partners
HBM Partners investment in Series B - Odyssey Therapeutics
Woodline Partners
Woodline Partners investment in Series A - Odyssey Therapeutics
SR One
SR One investment in Series A - Odyssey Therapeutics
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Series A - Odyssey Therapeutics
Creacion Ventures
Creacion Ventures investment in Series A - Odyssey Therapeutics
Colt Ventures
Colt Ventures investment in Series A - Odyssey Therapeutics
Foresite Capital
Foresite Capital investment in Series A - Odyssey Therapeutics
OrbiMed
OrbiMed investment in Series A - Odyssey Therapeutics
Logos Capital
Logos Capital investment in Series A - Odyssey Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-05-24 | Odyssey Therapeutics Appoints Darryl Patrick, D.V.M., Ph.D., as Executive Vice President of Non-Clinical Development |
Official Site Inspections
http://www.odysseytx.com Semrush global rank: 4.26 M Semrush visits lastest month: 2.73 K
- Host name: 172.67.130.57
- IP address: 172.67.130.57
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
